MOVE

MOVE

• CEO:
• Employees:
• Sector:
• Industry:

MOVE News

Latest news about the MOVE

• 
  Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO

  As the pioneer of the first FDA-approved continuous glucose monitor, Dr. Mastrototaro will be integral in advancing the development and regulatory process of the Company's glucose and blood pressure monitoring technologyPLEASANTON, CA / ACCESSWIRE / March 25, 2021 / Today, Movano Inc.

  View More →
• 
  Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option

  PLEASANTON, CA / ACCESSWIRE / March 25, 2021 /Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to prevent and better manage chronic diseases, has closed its previously announced initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.

  View More →
• 
  Movano Inc. Prices $42.5 Million Public Offering of Common Stock

  PLEASANTON, CA / ACCESSWIRE / March 23, 2021 / Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to prevent and better manage chronic diseases, announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.

  View More →